Eye Diseases
Showing NaN - NaN of 5
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)
Recruiting
- Retinitis Pigmentosa
- +7 more
- Ultevursen
- Sham-procedure
-
San Diego, California
- +14 more
Jul 29, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)
Active, not recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure
-
Dallas, Texas
- +2 more
Apr 21, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose
Completed
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure (dose cohort 1&2 only)
-
Boston, Massachusetts
- +6 more
Apr 19, 2022
Rate of Progression in EYS Related Retinal Degeneration
Active, not recruiting
- Retinitis Pigmentosa
- Eye Diseases
-
San Francisco, California
- +19 more
Feb 3, 2022
Keratoconus, Corneal Diseases, Eye Diseases Trial in United States (CXLO Corneal Strengthening Solution and UVA Illumination
Terminated
- Keratoconus
- +3 more
- CXLO Corneal Strengthening Solution and UVA Illumination Device
-
Scottsdale, Arizona
- +8 more
Dec 15, 2021